Application

19353269 · SELECTIVE TARGETING OF HOST CD70+ ALLOREACTIVE CELLS TO PROLONG ALLOGENEIC CAR T CELL PERSISTENCE

Filed 2025-10-08 · Pending The official file ↗ · Art unit 1631 · Examiner Jianjian Zhu Typical · CPC A61K 40/4224 · Allogene Therapeutics, Inc. · Allogene Therapeutics, Inc.

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

6.0 mo

to disposition n/a

Statutes raised

103 112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.